Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Blood Test Identifies Patients Prone to Serious Illness Post-Surgery

By LabMedica International staff writers
Posted on 22 Jun 2015
A simple blood test can predict with a high degree of accuracy whether a patient is likely to suffer life-threatening complications after major surgery

Key differences in a person’s immune system caused by a group of white blood cells called monocytes can be used to predict who will recover well after surgery and who is likely to develop serious illnesses.

Scientists at Queen Mary University (London, UK) took blood samples from 39 patients before surgery on the first and second morning afterward who were undergoing major liver and pancreatic surgery. The team then looked at the patients’ monocytes to see how they respond to fragments of microbes found in the skin or gut that might be released during surgery. The team also examined the level of toll-like receptor proteins in the blood cells. These classes of proteins play a key role in the immune system and are produced by monocytes.

During the study, 12 patients developed serious post-surgery complications and the team found their monocytes behaved very differently to the monocytes found in the blood of the 27 patients who recovered without complication. In addition, by measuring the amount of toll-like receptor proteins in the blood, the team was able to predict with 90% to 100% accuracy that would develop complications compared to 70% with routine tests. These findings were then confirmed in a second group of 30 patients undergoing similar operations.

Serum interleukin (IL)-6 concentration and monocyte Toll-like receptor (TLR)/NF-κB/IL-6 functional pathways were significantly upregulated and overactive in patients who developed systemic inflammatory response syndrome (SIRS). Interferon-α mediated signal transducer and activator of transcription 1 (STAT1) phosphorylation was higher preoperatively in patients who developed SIRS. Increased TLR4 and TLR5 gene expression in whole blood was demonstrated in a separate validation cohort of 30 patients undergoing similar surgery. Expression of TLR4/5 on monocytes, particularly intermediate CD14++CD16+ monocytes, on day one or two predicted SIRS with accuracy of 89% to 100%

William Alazawi, MB, PhD, who led the study said, “This study has given us an important insight into the way in which postoperative complications and infections arise. Patients who develop infections may have an immune system which is predisposed to overreact to surgery or the hospital environment and we need to do further research to fully understand this predisposition. If we can more accurately predict who will run into trouble after an operation, we can tailor personalized treatments to prevent complications and improve survival rates after major surgery. This is particularly the case if we can predict Systemic Inflammatory Response Syndrome before the operation has even taken place.” The study was published on June 7, 2015, in the journal Annals of Surgery.

Related Links:

Queen Mary University 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Real-time PCR System
GentierX3 Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.